From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...

The Alliance for Clinical Trials in Oncology has launched a new clinical trial for adults who need first-line therapy for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The ...

BTK inhibitor monotherapy is foundational across several B-cell malignancies, with newer, more selective agents designed to preserve efficacy while improving tolerability relative to first-in-class ...

Chinese scientists have improved upon an existing powerful leukemia treatment, which now works even when cancer cells try to ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

March is Colon Cancer Awareness month. According to a study published in January 2026 by the Journal of American Medical Association, colorectal cancer is now t ...

A team of Santa Barbara high school students leading a fundraising campaign for Blood Cancer United will host a community fundraiser Wednesday, March 18 ...

Colon cancer in people under 50 years of age is on the rise. According to a new study published in January by the Journal of American Medical ...

March is Colon Cancer Awareness month. According to a study published in January 2026 by the Journal of American Medical Association, colorectal cancer is now the leading cause of cancer-related death ...

Dr. Will Parsons, of Texas Children’s, discusses evolving therapies, survivorship clinics and tools like Passport For Care for long-term cancer care. For a child diagnosed with cancer, cure is the ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology.